Featured
Presenting Lynton’s Rebright 585nm Global leaders in the treatment of vascular lesions
Do you want to set a new standard for your practice in the treatment of vascular lesions? Look no further than Lynton’s Rebright 585nm...
ASOHNs v AHPRA: right to use the title ‘facial plastic surgeon’ goes to court
The Australian Society of Head and Neck Surgeons (ASOHNS), the representative body for ENT doctors, has taken legal action in the Federal Court seeking...
Facelifts & Gen Z; AAFPRS unveils aesthetic trends from annual member survey
The demand for facial plastic surgery and non-invasive treatments continues to surge, according to the recently released 2023 member survey outcomes by the American...
Cynosure and Lutronic announce merger
Cynosure and Hahn & Company, which recently acquired Lutronic, have announced their definitive merger agreement for a strategic combination of Cynosure and Lutronic.
Both Cynosure...
Ozempic, Wegovy, do not increase risk of pancreatic cancer: new study
A new study, published in JAMA, has found that glucagon-like peptide-1 receptor agonists (GLP-1RA) – such as Ozempic, Wegovy and Mounjaro – do not...
‘Menopause makeovers’, ‘Ozempic facelifts’ to trend in 2024
A recent article in Allure.com interviewed a number of US board-certified plastic surgeons who shared their prediction of top cosmetic surgery trends of 2024.
‘Menopause...
